AgomAb Therapeutics NV (AGMB)
7.76
-0.64
(-7.62%)
USD |
NASDAQ |
Oct 28, 16:00
8.11
+0.35
(+4.51%)
After-Hours: 20:00
AgomAb Therapeutics Price to Book Value
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 27, 2026 | 2.663 |
| October 26, 2026 | 2.717 |
| October 23, 2026 | 2.869 |
| October 22, 2026 | 2.936 |
| October 21, 2026 | 2.888 |
| October 20, 2026 | 2.768 |
| October 19, 2026 | 2.609 |
| October 16, 2026 | 2.625 |
| October 15, 2026 | 2.641 |
| October 14, 2026 | 2.755 |
| October 13, 2026 | 2.793 |
| October 12, 2026 | 2.882 |
| October 09, 2026 | 2.878 |
| October 08, 2026 | 2.923 |
| October 07, 2026 | 2.790 |
| October 06, 2026 | 2.802 |
| October 05, 2026 | 2.755 |
| October 02, 2026 | 2.714 |
| October 01, 2026 | 2.742 |
| September 30, 2026 | 3.519 |
| September 29, 2026 | 3.338 |
| September 28, 2026 | 3.237 |
| September 25, 2026 | 3.332 |
| September 24, 2026 | 3.354 |
| September 23, 2026 | 3.413 |
| Date | Value |
|---|---|
| September 22, 2026 | 3.642 |
| September 21, 2026 | 3.709 |
| September 18, 2026 | 3.858 |
| September 17, 2026 | 3.830 |
| September 16, 2026 | 3.617 |
| September 15, 2026 | 3.855 |
| September 14, 2026 | 3.893 |
| September 11, 2026 | 4.140 |
| September 10, 2026 | 4.419 |
| September 09, 2026 | 4.742 |
| September 08, 2026 | 4.727 |
| September 04, 2026 | 5.002 |
| September 03, 2026 | 4.701 |
| September 02, 2026 | 4.330 |
| September 01, 2026 | 4.292 |
| August 31, 2026 | 4.175 |
| August 28, 2026 | 4.175 |
| August 27, 2026 | 4.388 |
| August 26, 2026 | 4.527 |
| August 25, 2026 | 4.444 |
| August 24, 2026 | 4.064 |
| August 21, 2026 | 4.200 |
| August 20, 2026 | 4.258 |
| August 19, 2026 | 4.359 |
| August 18, 2026 | 4.353 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Cocrystal Pharma, Inc. | 13.21 |
| CNBX Pharmaceuticals, Inc. | -- |
| Invion Ltd. | -- |
| Arvinas, Inc. | 0.8816 |
| Fulcrum Therapeutics, Inc. | 0.9257 |
Price to Book Value Related Metrics
| Price | 7.76 |
| Market Cap | 382.16M |